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Objectives:Socio-cultural factorshavebeenhypothesized tobe importantdrivers for inappropriateantibiotic prescrib-
ing in ambulatory care. This study sought to assess any potential role in perioperative surgical prophylaxis (PAP) admi-
nistered for .24 h (PAP.24). Within hospitals, PAP continues to be administered for longer than 24 h, despite
unequivocal evidence of ineffectiveness beyond this period. A recently published European Centre for Disease Preven-
tionandControl (ECDC) point prevalence survey (PPS) has reported that in 70%of participating countries, PAP.24was
administered in more than half of the surgical operations surveyed.
Methods:Correlationand simple linear regressionmodellingwas performedusing the PAP.24proportions for the
countries in the ECDC PPS report and the respective scores for the cultural construct of uncertaintyavoidance (UA),
as detailed by Hofstede.
Results: Pearson correlation analysis produced a moderately strong coefficient (r) of 0.50 (95% CI 0.16–0.74;
P¼0.007). Simple regression yielded a model of PAP.24¼29.87+0.40UA (R2¼0.25; P¼0.007).
Conclusions: Cultural factors, namely UA, appear to be an important driver for PAP.24. Any strategy aimed at
improving prolonged PAP should be informed by clear knowledge of local socio-cultural barriers, so as to
achieve the most successful intervention possible.
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Introduction
As part of a bundle ofmeasures, perioperative surgical prophylaxis
(PAP) is a valuable tool to reduce post-operative surgical site infec-
tions.1 It has long been acknowledged that the duration of PAP
should not exceed 24 h and that excessively prolonged PAP
beyond this time period offers no additional benefit.2 Indeed,
prolonged PAP has been shown to be a driver for the development
of antimicrobial resistance.3 Nevertheless, a recently published
European Centre for Disease Prevention and Control (ECDC) point
prevalence survey (PPS) of healthcare-associated infections and
antimicrobial use in European acute care hospitals reported that,
in 70% of participating countries, PAP beyond 24 h (PAP.24)
was administered in more than half of the surgical operations
surveyed.4 In seven countries, PAP.24 was administered to
.75% of patients.
Cultural factors have been proposed as important drivers for in-
appropriate antibiotic prescribingwithin community care.5,6 These
studies have identified the cultural anthropological dimension of
uncertainty avoidance (UA) as being particularly relevant in
explaining why doctors in some European countries have a
greater propensity to prescribe antibiotics for predominantly viral
conditions such as colds, flu and sore throat, in the face of clear
scientific evidence. UA is described in Geert Hofstede’s model of
cultural dimensions as a construct estimating the extent to
which a society tolerates uncertainty and ambiguity.6,7 Such
cultures often try to counteract the unease created by situations
of uncertainty through the adoption of dogmatic and excessive
measures, even where there is no evidence of cost-effectiveness
or risk attenuation. Outcomeuncertainty related to post-operative
surgical site infection complications could offer a theoretically
plausible behavioural explanation for PAP.24 practices. The
study therefore sought to identify correlations between PAP.24
and the respective national UA scores reported by Hofstede.
Methods
For the purpose of the study, dataonPAP.24were extracted fromthe ECDC
PPS 2011–12 report. These related to the proportion of PAP given for more
than 1 day as a percentage of the total antimicrobials prescribed for PAP,
by country. Proportions from two countries (Denmark and Sweden) were
excluded since they were indicated in the PPS report as having very poor na-
tional representativeness in termsofnumbersandcharacteristics. Individual
scores for UAwere collated for each country from Hofstede’s publicly avail-
able resource accessed at http://www.geerthofstede.nl/research--vsm. Re-
spective data per country were then inputted in Excel (Microsoft Excel
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2003, Microsoft Corp.) for preliminary evaluation. Pearson correlation was
used to compare proportions of PAP.24, arranged hierarchically, versus
their respectiveUAcountryscores. A simple linear regressionmodelwassub-
sequently constructed using the same two sets of data. Analyses were per-
formedinMedcalc,version12.5.0.0(MedcalcSoftware,Mariakerke,Belgium).
A P value of 0.05 was taken to indicate statistical significance.
Results
PAP.24 in the countries performing the ECDC PPS ranged from
29.1% in UK (England) to 92.3% in Romania (Table 1). Pearson
correlation analysis between PAP.24 proportions and UA scores
for the same country produced a coefficient (r) of 0.50 (95% CI
0.16–0.74) and a P value of 0.007. Simple regression yielded a
model of PAP.24¼29.87+0.40UA (R2¼0.25; P¼0.007). All the
data points fitted into the 95% prediction interval with the
exception of Belgium (Figure 1). When the regression model
was repeated without the Belgian data, the model achieved a
coefficient of determination (R2) of 0.34 and P¼0.001.
Discussion
The regression model suggests that up to a third of the variation in
PAP.24 in Europe can be predicted from the national cultural
dimension of UA. Considering that these are totally dissimilar
measurements, such an association appears highly remarkable.
However, as in all suchmodels, it should be pointed out that correl-
ation does not automatically infer causality and potential confoun-
ders must always be kept in mind. Confounding from economic
factors is unlikely since no correlation was identified between
PAP.24 and GDP per capita or healthcare expenditure in the coun-
tries studied.However, the socio-demographic characteristicsof the
participating hospitals were not available for analysis; nevertheless,
the considerable number of hospitals involved in the ECDC PPS
wouldmake such confounding unlikely. In addition, the percentage
of prolonged PAP is by design overestimated in any PPS, but, due to
the standardized PPS protocol, any overestimation would be
uniform across all participants. This means that the inter-hospital
and inter-country comparisons of the indicator will remain valid.4
The identified correlation suggests a strong and plausible indi-
cation of concomitant variation. Just as community doctors in
high-UA countries have been hypothesized to prescribe antibiotics
for viral respiratory infections as a defensive response to their in-
herent cultural unease with ambiguity,5,6 it is logical to surmise
that hospital doctors in the same countries would similarly
prescribePAPbeyond its recommended24 hdurationoutof uncer-
tainty of outcome. Indeed, it is not uncommon to hear anecdotes
of ‘just in case’ approaches to hospital antibiotic prescribing during
conversations in Mediterranean regional meetings, where most
countries have high UA scores.
The possible role of inherent cultural factors has significant
relevance in terms of appropriate strategies to address PAP.24
in high-UA countries. Corrective initiatives are usually focused on
the production of guidelines, development of multidisciplinary
teams and emphasis on education.8 However, less than optimal
perceptions about guidelines have been reported among doctors
in high-UA countries. In such countries, personal experiences can
be regarded asmore important (and a greater source of certainty)
than evidence-based literature and genuine enthusiasm formulti-
disciplinary involvement may also often be absent.9
It is interesting to note that the only country to fall outside the
regressionmodel was Belgium. This country has a high UA score of
94 yet reported low proportions (35%) of PAP.24. However, this
was not always the case. In the 1980s, consistent with its UA
score, .50% of PAP given in Belgian hospitals exceeded even
48 h. It was only following a new refund system for perioperative
administration of antibiotics, introduced by Royal Decree in 1997,
that a sustained improvement was achieved.10 The new system
limited reimbursement of antimicrobial drug prophylaxis to specif-
icagentsandonly fora24 hperiodaftersurgery. It alsoestablished
afixed fee forantimicrobial costs attributable to each type of inter-
vention.11 Such a top-down intervention would have been highly
compatible with culture change in high-UA settings. It can be
hypothesized that the direct uncertainty of financial losses from
lack of reimbursement, introduced by the intervention, would
have immediately become the most important element of
Table 1. PAP.24 proportions as reported in the ECDC PPS report together
with concomitant UA scores for the respective countries (sourced from
http://www.geerthofstede.nl/research--vsm, unless otherwise indicated)
Country UA score PAP.24 (%)
Austria 70 77.2
Belgium 94 35.0
Bulgaria 85 79.5
Croatia 80 67.3
Cyprus 112a 76.3
Czech Republic 74 49.6
Denmark poor PPS representativeness
Estonia 60 62.9
Finland 59 42.7
France 86 68.4
Germany 65 70.2
Greece 112 79.5
Hungary 82 53.5
Iceland 49b 37.2
Ireland 35 46.7
Italy 75 63.5
Latvia 63 55.4
Lithuania 65 55.0
Luxembourg 70 59.4
Malta 96 82.7
Netherlands 53 53.6
Norway 50 30.1
Poland 93 43.5
Portugal 104 66.5
Romania 90 92.3
Slovakia 51 81.5
Slovenia 88 58.3
Spain 86 53.3
Sweden poor PPS representativeness
UK (England) 35 29.1
Additional data sources:
ahttp://www.econ.uniurb.it/materiale/7716_Dimitratos%20et%20al%
202011.pdf.
bhttp://web.cs.wpi.edu/~kal/elearn/elearn05.pdf.
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ambiguity in the antibiotic decision-making process and would
have overcome the dogma of unnecessarily prolonged PAP.
Cultural drivers have been shown to correlate with healthcare-
associated multiresistant infection outcomes.12 It should there-
fore not be unexpected to identify a similar link to related
processes, such as antibiotic prescribing. After all, both antibiotic
stewardship as well as infection prevention and control practices
deal as much with medical as with behavioural science. It is clear
that there is no ‘one size fits all’ solution to address PAP.24 in
European countries. Any strategy must be informed by a clear
knowledge of local socio-cultural barriers in order to achieve the
most appropriate and effective interventions.
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Figure 1. Scatter diagramof UA scores and PAP.24 percentages for ECDC PPS countries with regression (continuous) and 95%prediction (broken) lines.
The circled outlier corresponds to Belgium.
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